Skip to main content
. Author manuscript; available in PMC: 2013 Jun 17.
Published in final edited form as: J Pharm Sci. 2010 Jun;99(6):2643–2654. doi: 10.1002/jps.22055

Table 2.

Physical Stability of PRL-1a

Phosphate HEPES
CD SLS CD SLS

Tm ± SD Onset T ± SD Tm ± SD Onset T ± SD
oxWT 65.47 1.11 59.92 0.28 60.54 2.08 53.27 0.35
redWTbc 67.81 0.43 63.75 0.38 61.98 1.26 57.35 0.32
redWTd 79.01e 0.66 ndf nd nd
C49S 62.79 2.00 59.68 0.22 56.25 0.32 49.95 0.32
C104S 76.31 1.07 72.1 0.32 64.85 2.06 59.28 0.22
Y53E 62.25 0.35 nd nd nd
Y53F 62.61 0.30 nd nd nd
a

All temperatures reported are in °C

b

For CD, reducing conditions were achieved by the addition of 1 mM DTT. For SLS, reducing conditions were achieved by the addition of 10 mM DTT.

c

CD and/or SLS were also used to study the physical stability of PRL-1 mutants under both reducing and nonreducing conditions, although no differences were detected. This data for this is not shown.

d

Reduced PRL-1-WT (redWT) was studied in 20 mM phosphate buffer at pH 6.5 with equivalent ionic strength (I=100 mM). All other values reported, including those for HEPES buffer, are at pH 7.5.

e

Melting was incomplete at the maximum temperature attainable and the data was extrapolated to determine the Tm.

f

Not determined